TCL Archive In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available July 1, 1977
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014